Gofen & Glossberg’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $692K | Sell |
5,425
-480
| -8% | -$55.7K | 0.02% | 292 |
|
|
2022
Q3 | $617K | Buy |
5,905
+340
| +6% | +$37.3K | 0.02% | 283 |
|
|
2022
Q2 | $585K | Sell |
5,565
-10
| -0.2% | -$1.19K | 0.02% | 289 |
|
|
2022
Q1 | $713K | Buy |
5,575
+234
| +4% | +$28.2K | 0.02% | 281 |
|
|
2021
Q4 | $659K | Sell |
5,341
-24
| -0.4% | -$3.14K | 0.01% | 307 |
|
|
2021
Q3 | $762K | Sell |
5,365
-243
| -4% | -$35.7K | 0.02% | 273 |
|
|
2021
Q2 | $876K | Hold |
5,608
| – | – | 0.02% | 254 |
|
|
2021
Q1 | $872K | Hold |
5,608
| – | – | 0.02% | 248 |
|
|
2020
Q4 | $839K | Sell |
5,608
-103
| -2% | -$14.5K | 0.02% | 249 |
|
|
2020
Q3 | $755K | Hold |
5,711
| – | – | 0.02% | 245 |
|
|
2020
Q2 | $662K | Hold |
5,711
| – | – | 0.02% | 246 |
|
|
2020
Q1 | $560K | Sell |
5,711
-433
| -7% | -$56.8K | 0.02% | 248 |
|
|
2019
Q4 | $893K | Hold |
6,144
| – | – | 0.03% | 223 |
|
|
2019
Q3 | $819K | Hold |
6,144
| – | – | 0.03% | 226 |
|
|
2019
Q2 | $702K | Buy |
6,144
+8
| +0.1% | +$937 | 0.02% | 242 |
|
|
2019
Q1 | $761K | Buy |
6,136
+515
| +9% | +$58.5K | 0.03% | 223 |
|
|
2018
Q4 | $566K | Buy |
5,621
+151
| +3% | +$17K | 0.02% | 248 |
|
|
2018
Q3 | $698K | Hold |
5,470
| – | – | 0.02% | 240 |
|
|
2018
Q2 | $592K | Sell |
5,470
-234
| -4% | -$25.5K | 0.02% | 254 |
|
|
2018
Q1 | $604K | Sell |
5,704
-211
| -4% | -$24.5K | 0.02% | 255 |
|
|
2017
Q4 | $693K | Sell |
5,915
-62
| -1% | -$7.01K | 0.02% | 248 |
|
|
2017
Q3 | $679K | Sell |
5,977
-265
| -4% | -$30.6K | 0.03% | 250 |
|
|
2017
Q2 | $778K | Buy |
6,242
+166
| +3% | +$19.7K | 0.03% | 236 |
|
|
2017
Q1 | $720K | Buy |
6,076
+439
| +8% | +$49.8K | 0.03% | 244 |
|
|
2016
Q4 | $565K | Buy |
5,637
+434
| +8% | +$46.5K | 0.02% | 264 |
|
|
2016
Q3 | $657K | Sell |
5,203
-257
| -5% | -$31.8K | 0.03% | 244 |
|
|
2016
Q2 | $638K | Buy |
5,460
+98
| +2% | +$11.1K | 0.03% | 249 |
|
|
2016
Q1 | $555K | Buy |
5,362
+65
| +1% | +$6.29K | 0.02% | 264 |
|
|
2015
Q4 | $528K | Sell |
5,297
-83
| -2% | -$8.12K | 0.02% | 269 |
|
|
2015
Q3 | $491K | Sell |
5,380
-618
| -10% | -$62K | 0.02% | 276 |
|
|
2015
Q2 | $636K | Hold |
5,998
| – | – | 0.03% | 252 |
|
|
2015
Q1 | $684K | Buy |
5,998
+155
| +3% | +$17.7K | 0.03% | 246 |
|
|
2014
Q4 | $643K | Sell |
5,843
-196
| -3% | -$20.7K | 0.03% | 251 |
|
|
2014
Q3 | $590K | Hold |
6,039
| – | – | 0.03% | 249 |
|
|
2014
Q2 | $609K | Hold |
6,039
| – | – | 0.03% | 242 |
|
|
2014
Q1 | $550K | Buy |
6,039
+52
| +0.9% | +$4.79K | 0.03% | 252 |
|
|
2013
Q4 | $542K | Hold |
5,987
| – | – | 0.03% | 251 |
|
|
2013
Q3 | $477K | Hold |
5,987
| – | – | 0.02% | 259 |
|
|
2013
Q2 | $436K | Buy |
+5,987
| New | +$448K | 0.02% | 251 |
|
Other funds holding ZBH
Gofen & Glossberg's ZBH Position: Q4 2022 in Review
Gofen & Glossberg reduced its Zimmer Biomet (ZBH) stake by 8.1% in Q4 2022, selling an estimated $55.7K and leaving 5,425 shares worth $692K. The position accounts for 0.02% of the portfolio, ranked #292.
Gofen & Glossberg first reported a position in ZBH in Q2 2013 and has held it in 39 quarters since. The position peaked at $893K in Q4 2019. 978 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.
- Gofen & Glossberg held 5,425 shares of Zimmer Biomet worth $692K as of Q4 2022.
- Gofen & Glossberg sold 480 Zimmer Biomet shares in Q4 2022, an estimated $55.7K.
- Zimmer Biomet made up 0.02% of Gofen & Glossberg's portfolio in Q4 2022, its #292 holding.
- Gofen & Glossberg first reported a position in Zimmer Biomet in Q2 2013 and has held it in 39 quarters since.
- Gofen & Glossberg's Zimmer Biomet position peaked at $893K in Q4 2019.
- 978 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.